UK markets open in 4 hours 24 minutes

ABIVAX Société Anonyme (AAVXF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
32.000.00 (0.00%)
At close: 08:30AM EST
Full screen
Loading interactive chart…
  • EQS Group

    ABIVAX: ABX464 shows excellent long-term efficacy data in Abivax's phase 2b maintenance Trial in ulcerative colitis

    DGAP-News: ABIVAX / Key word(s): Study results18.10.2021 / 18:00 The issuer is solely responsible for the content of this announcement.ABX464 shows excellent long-term efficacy data in Abivax's phase 2b maintenance Trial in ulcerative colitis Impressive clinical remission in 58.4% (ITT) of 101 patients after 48 weeks of once-daily oral 50mg ABX464, showing both maintained as well as further improved efficacy Favorable safety and tolerability profile continues to support ABX464 chronic use potent

  • EQS Group

    Abivax announces the release of its 2021 half-year financial report

    DGAP-News: ABIVAX / Key word(s): Half Year Report30.09.2021 / 18:00 The issuer is solely responsible for the content of this announcement.Abivax announces the release of its 2021 half-year financial report PARIS, France, September 30, 2021 - 6:00 pm (CEST) - Abivax SA (Euronext Paris: FR0012333284 - ABVX), a clinical-stage biotechnology company developing novel therapies that modulate the immune system to treat chronic inflammatory diseases, viral infections, and cancer, today announces the publ

  • EQS Group

    Abivax late-breaking abstract presentation and Live Industry Symposium at the UEG Week Virtual 2021

    DGAP-News: ABIVAX / Key word(s): Conference28.09.2021 / 18:00 The issuer is solely responsible for the content of this announcement.Abivax late-breaking abstract presentation and Live Industry Symposium at the UEG Week Virtual 2021Principal investigator Prof. Séverine Vermeire, M.D., Ph.D, to present Abivax's late-breaking abstract on ABX464 phase 2b study results in ulcerative colitis (UC)October 4, 2021, at 10:42-10:54 am CESTAbivax will also be hosting a Live Industry Symposium on ABX464's po